iSpecimen Inc. is a technology-driven company. The Company addresses a critical challenge, which focuses on connecting life science researchers who need human biofluids, tissues, and living cells (biospecimens) for their research. The Companyâs iSpecimen Marketplace platform is designed to solve this problem and transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. In addition to providing the technology platform to connect researchers and healthcare providers, the Company handles all marketing, sales, contracting, and compliance functions across both sides of the marketplace. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data and administrative, compliance and reporting.
äŒæ¥ã³ãŒãISPC
äŒç€ŸåiSpecimen Inc
äžå Žæ¥Jun 17, 2021
æé«çµå¶è²¬ä»»è
ãCEOãField (Katharyn)
åŸæ¥å¡æ°24
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Jun 17
æ¬ç€Ÿæåšå°8 Cabot Road
éœåžWOBURN
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·08101
é»è©±çªå·17813016700
ãŠã§ããµã€ãhttps://www.ispecimen.com/
äŒæ¥ã³ãŒãISPC
äžå Žæ¥Jun 17, 2021
æé«çµå¶è²¬ä»»è
ãCEOãField (Katharyn)
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã